Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
Cancer Cell International,
Abstract Background About 30% of Prostate cancer (PCa) patients progress to metastatic PCa that remains largely incurable.